NH
Narayana Hrudayalaya Ltd.
Bengaluru-based hospital network — multispecialty, tertiary and primary care
Healthcare›Healthcare›Healthcare Services›Hospital
narayanahealth.org(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
NH (Narayana Hrudayalaya) runs hospitals and heart centres in India, with clinics around them, and also operates hospitals in Cayman and, since November 2025, in the United Kingdom.
Company snapshot
6thBy market cap
Ranked among 24 companies in Hospital.
Segment mix
Reportable segments as of 2024-12-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.
Largest segment: 100.0% of revenue
| Segment | Revenue share | Revenue | PBT | Assets |
|---|---|---|---|---|
| Less: Inter segment revenue | — | -8 Cr | 0 Cr | 0 Cr |
| Medical and healthcare related services | 100.0% | 1,367 Cr | 247 Cr | 5,299 Cr |
| Others | 0.6% | 8 Cr | -10 Cr | 134 Cr |
| Unallocated other income | 1.3% | 18 Cr | 18 Cr | 0 Cr |
Shares add up to 102% because segment revenues are before inter-segment eliminations.
What we see
- ✓91% of operating profit came in as cash over the last three years — profits are backed by real cash.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,305 Cr | 1,204 Cr | 1,279 Cr | 1,341 Cr | 1,400 Cr | 1,367 Cr | 1,475 Cr | 1,507 Cr | 1,644 Cr | 2,151 Cr | 2,594 Cr | 2,684 Cr |
| Operating expenses (approx.) | 997 Cr | 925 Cr | 985 Cr | 1,037 Cr | 1,092 Cr | 1,060 Cr | 1,118 Cr | 1,170 Cr | 1,241 Cr | 1,784 Cr | 2,084 Cr | 2,214 Cr |
| EBITDA | 308 Cr | 279 Cr | 295 Cr | 304 Cr | 308 Cr | 307 Cr | 358 Cr | 337 Cr | 403 Cr | 367 Cr | 510 Cr | 470 Cr |
| OPM % | 23.6% | 23.2% | 23.0% | 22.7% | 22.0% | 22.5% | 24.2% | 22.4% | 24.5% | 17.1% | 19.7% | 17.5% |
| Other income | 18 Cr | 18 Cr | 24 Cr | 23 Cr | 24 Cr | 18 Cr | 27 Cr | 24 Cr | 24 Cr | 23 Cr | 29 Cr | 35 Cr |
| Interest | 23 Cr | 25 Cr | 28 Cr | 34 Cr | 35 Cr | 37 Cr | 41 Cr | 45 Cr | 42 Cr | 65 Cr | 91 Cr | 87 Cr |
| Depreciation | 55 Cr | 63 Cr | 65 Cr | 62 Cr | 65 Cr | 70 Cr | 83 Cr | 84 Cr | 87 Cr | 122 Cr | 154 Cr | 156 Cr |
| Profit before tax | 248 Cr | 209 Cr | 226 Cr | 232 Cr | 232 Cr | 219 Cr | 255 Cr | 232 Cr | 296 Cr | 149 Cr | 289 Cr | 260 Cr |
| Tax % | 8.7% | 9.8% | 15.4% | 13.0% | 14.2% | 11.8% | 22.6% | 15.1% | 12.6% | 14.9% | 22.4% | 20.4% |
| Net profit | 227 Cr | 188 Cr | 191 Cr | 201 Cr | 199 Cr | 193 Cr | 197 Cr | 197 Cr | 258 Cr | 127 Cr | 224 Cr | 207 Cr |
| EPS (₹) | ₹11.16 | ₹9.26 | ₹9.39 | ₹9.92 | ₹9.78 | ₹9.50 | ₹9.71 | ₹9.68 | ₹12.72 | ₹6.24 | ₹11.02 | ₹10.20 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,878 Cr | 2,281 Cr | 2,861 Cr | 3,128 Cr | 2,582 Cr | 3,701 Cr | 4,525 Cr | 5,018 Cr | 5,483 Cr | 7,896 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 1,649 Cr | 2,069 Cr | 2,573 Cr | 2,705 Cr | 2,400 Cr | 3,048 Cr | 3,559 Cr | 3,866 Cr | 4,207 Cr | 6,279 Cr | Sign in free for the trailing twelve months |
| EBITDA | 229 Cr | 212 Cr | 288 Cr | 423 Cr | 182 Cr | 654 Cr | 966 Cr | 1,152 Cr | 1,276 Cr | 1,617 Cr | Sign in free for the trailing twelve months |
| OPM % | 12.2% | 9.3% | 10.1% | 13.5% | 7.1% | 17.7% | 21.3% | 23.0% | 23.3% | 20.5% | Sign in free for the trailing twelve months |
| Other income | 17 Cr | 19 Cr | 17 Cr | 24 Cr | 28 Cr | 35 Cr | 65 Cr | 75 Cr | 92 Cr | 100 Cr | Sign in free for the trailing twelve months |
| Interest | 22 Cr | 47 Cr | 71 Cr | 85 Cr | 76 Cr | 66 Cr | 69 Cr | 97 Cr | 146 Cr | 244 Cr | Sign in free for the trailing twelve months |
| Depreciation | 80 Cr | 100 Cr | 137 Cr | 186 Cr | 184 Cr | 183 Cr | 210 Cr | 242 Cr | 278 Cr | 448 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 135 Cr | 80 Cr | 93 Cr | 161 Cr | -56 Cr | 430 Cr | 752 Cr | 889 Cr | 937 Cr | 965 Cr | Sign in free for the trailing twelve months |
| Tax % | 38.7% | 36.0% | 36.5% | 26.2% | 74.5% | 20.4% | 19.3% | 11.1% | 15.6% | 16.5% | Sign in free for the trailing twelve months |
| Net profit | 83 Cr | 51 Cr | 59 Cr | 119 Cr | -14 Cr | 342 Cr | 607 Cr | 790 Cr | 791 Cr | 806 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹4.10 | ₹2.53 | ₹2.92 | ₹5.86 | ₹-0.70 | ₹16.85 | ₹29.85 | ₹38.86 | ₹38.90 | ₹39.67 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | — | — | 0.0% | 3.3% | 6.4% | 10.3% | 11.3% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 204 Cr | 204 Cr | 204 Cr | 204 Cr | 204 Cr | 204 Cr | 204 Cr | 204 Cr | 204 Cr | 204 Cr |
| Reserves | 759 Cr | 831 Cr | 877 Cr | 932 Cr | 916 Cr | 1,284 Cr | 1,927 Cr | 2,679 Cr | 3,422 Cr | 4,333 Cr |
| Borrowings | 189 Cr | 734 Cr | 737 Cr | 629 Cr | 525 Cr | 545 Cr | 762 Cr | 1,444 Cr | 2,213 Cr | 4,866 Cr |
| Other liabilities | 495 Cr | 766 Cr | 819 Cr | 1,125 Cr | 1,124 Cr | 1,095 Cr | 1,267 Cr | 1,296 Cr | 1,423 Cr | 3,069 Cr |
| Total liabilities | 1,647 Cr | 2,536 Cr | 2,637 Cr | 2,891 Cr | 2,770 Cr | 3,130 Cr | 4,162 Cr | 5,625 Cr | 7,265 Cr | 12,474 Cr |
| Fixed assets (net) | 1,021 Cr | 1,712 Cr | 1,712 Cr | 1,725 Cr | 1,644 Cr | 1,707 Cr | 1,923 Cr | 2,198 Cr | 3,814 Cr | 4,527 Cr |
| CWIP | 53 Cr | 35 Cr | 36 Cr | 12 Cr | 18 Cr | 63 Cr | 259 Cr | 514 Cr | 70 Cr | 267 Cr |
| Investments | 96 Cr | 9 Cr | 17 Cr | 86 Cr | 118 Cr | 132 Cr | 252 Cr | 844 Cr | 1,084 Cr | 547 Cr |
| Loans & advances | — | — | 3 Cr | 8 Cr | 4 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr |
| Inventories | 52 Cr | 84 Cr | 83 Cr | 60 Cr | 48 Cr | 59 Cr | 72 Cr | 110 Cr | 110 Cr | 155 Cr |
| Trade receivables | 157 Cr | 279 Cr | 266 Cr | 262 Cr | 279 Cr | 437 Cr | 432 Cr | 422 Cr | 555 Cr | 656 Cr |
| Cash & bank | 26 Cr | 33 Cr | 96 Cr | 103 Cr | 111 Cr | 157 Cr | 155 Cr | 264 Cr | 457 Cr | 770 Cr |
| Other assets | 241 Cr | 384 Cr | 422 Cr | 635 Cr | 549 Cr | 575 Cr | 1,070 Cr | 1,272 Cr | 1,174 Cr | 5,554 Cr |
| Total assets | 1,647 Cr | 2,536 Cr | 2,637 Cr | 2,891 Cr | 2,770 Cr | 3,130 Cr | 4,162 Cr | 5,625 Cr | 7,265 Cr | 12,474 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 219 Cr | 182 Cr | 279 Cr | 443 Cr | 309 Cr | 485 Cr | 1,085 Cr | 1,067 Cr | 990 Cr | 1,618 Cr |
| Cash from investing | -146 Cr | -534 Cr | -161 Cr | -189 Cr | -113 Cr | -267 Cr | -1,174 Cr | -1,458 Cr | -1,317 Cr | -3,653 Cr |
| Cash from financing | -45 Cr | 315 Cr | -27 Cr | -247 Cr | -198 Cr | -159 Cr | 88 Cr | 488 Cr | 532 Cr | 2,343 Cr |
| Net cash flow | 28 Cr | -36 Cr | 90 Cr | 8 Cr | -2 Cr | 59 Cr | -4 Cr | 97 Cr | 205 Cr | 313 Cr |
| Free cash flow (OCF − Capex) | 84 Cr | -21 Cr | 129 Cr | 327 Cr | 239 Cr | 234 Cr | 563 Cr | 96 Cr | -84 Cr | 744 Cr |
Ratios
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 13.6% | 7.2% | 9.1% | 14.0% | 1.2% | 24.4% | 28.4% | 22.8% | 18.5% | 12.9% |
| ROE % | 8.6% | 5.0% | 5.5% | 10.5% | -1.3% | 23.0% | 28.4% | 27.4% | 21.8% | 17.7% |
| Debtor days | 30 | 45 | 34 | 31 | 39 | 43 | 35 | 31 | 37 | 30 |
| Inventory days | 10 | 13 | 11 | 7 | 7 | 6 | 6 | 8 | 7 | 7 |
| Days payable | 40 | 47 | 42 | 42 | 58 | 44 | 49 | 44 | 38 | 48 |
| Cash conversion cycle | 1 | 11 | 2 | -5 | -12 | 5 | -9 | -5 | 6 | -10 |
| OCF / EBITDA % | 95.8% | 85.9% | 96.8% | 104.8% | 169.7% | 74.2% | 112.3% | 92.6% | 77.6% | 100.1% |
| OCF / EBITDA % (3 years) | — | — | 93.3% | 98.0% | 115.5% | 98.3% | 104.3% | 95.1% | 92.5% | 90.8% |
| Debt / equity | 0.20 | 0.71 | 0.68 | 0.55 | 0.47 | 0.37 | 0.36 | 0.50 | 0.61 | 1.07 |
| Current ratio | 0.93 | 0.94 | 1.03 | 0.98 | 0.95 | 1.17 | 1.31 | 1.75 | 2.18 | 2.15 |
| Net debt / EBITDA | 0.71 | — | 2.22 | 1.25 | 2.28 | 0.59 | 0.63 | 1.02 | 1.38 | 2.53 |